Lakefront Biotherapeutics NV GLPGF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 06/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -29.53% | -3.52% | 9.06% | -1.22% | -1.22% |
| Total Receivables | -37.65% | -30.96% | -30.93% | -5.18% | -5.18% |
| Inventory | -75.40% | -51.00% | -50.17% | -41.54% | -41.54% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -88.53% | -86.39% | -92.36% | -33.83% | -33.83% |
| Total Current Assets | -30.99% | -5.97% | 4.58% | -2.65% | -2.65% |
|
|
|||||
| Total Current Assets | -30.99% | -5.97% | 4.58% | -2.65% | -2.65% |
| Net Property, Plant & Equipment | -31.81% | -27.50% | -25.57% | -6.43% | -6.43% |
| Long-term Investments | -- | -- | -- | 8.61% | 8.61% |
| Goodwill | -- | -- | -- | 8.61% | 8.61% |
| Total Other Intangibles | 395.33% | -99.49% | -99.42% | -11.48% | -11.48% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -28.00% | 24.40% | 21.58% | 7.76% | 7.76% |
| Total Assets | -14.62% | -10.55% | -6.59% | -2.46% | -2.46% |
|
|
|||||
| Total Accounts Payable | -51.54% | -39.53% | -62.58% | 13.76% | 13.76% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -35.40% | -44.98% | -43.64% | -36.40% | -36.40% |
| Total Finance Division Other Current Liabilities | -99.13% | -98.76% | -42.26% | 26.13% | 26.13% |
| Total Other Current Liabilities | -99.13% | -98.76% | -42.26% | 26.13% | 26.13% |
| Total Current Liabilities | -83.02% | -75.49% | -48.26% | 21.08% | 21.08% |
|
|
|||||
| Total Current Liabilities | -83.02% | -75.49% | -48.26% | 21.08% | 21.08% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -23.25% | -33.55% | -28.65% | -1.75% | -1.75% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -98.42% | -98.23% | -98.40% | -16.82% | -16.82% |
| Total Liabilities | -92.75% | -90.03% | -84.38% | -6.73% | -6.73% |
|
|
|||||
| Common Stock & APIC | -2.72% | 6.68% | 13.41% | 9.61% | 9.61% |
| Retained Earnings | 159.77% | 186.74% | 277.81% | -251.17% | -251.17% |
| Treasury Stock & Other | 80.61% | -182.66% | -2,136.94% | -288.05% | -288.05% |
| Total Common Equity | 20.09% | 26.30% | 26.68% | -0.43% | -0.43% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 20.09% | 26.30% | 26.68% | -0.43% | -0.43% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 20.09% | 26.30% | 26.68% | -0.43% | -0.43% |
|
|
|||||